This webinar brings together three experts in the diagnosis and treatment of patients with dry eye disease (DED). Marc R. Bloomenstein, OD, FAAO, Selina R. McGee, OD, FAAO, DIPL ABO, and Leslie O’Dell, OD, FAAO, will discuss how DED can present as both an acute and a chronic disease and will also review the latest data on emerging therapies.
Supported by an unrestricted educational grant from Kala Pharmaceuticals
Upon completion of this activity, the participant should be able to:
Sponsored by:
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This activity, COPE Activity Number 122020, is accredited by COPE for continuing education for optometrists.
This course is approved for 1 hour CE.
Course #: 73152-AS
Activity ID: 122020
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Marc Bloomenstein, OD, FAAO
Schwartz Laser Eye Center
Director of Optometric Services
Scottsdale, AZ
Selina R. McGee, OD, FAAO, Dipl ABO
Founder
Precision Vision Oklahoma
Edmond, OK
Leslie O’Dell, OD, FAAO
Clinical Director
Medical Optometry America
York, PA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Marc Bloomenstein, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Bausch + Lomb, BioTissue, Johnson & Johnson Vision, Kala Pharmaceuticals, Ocusoft, Reichert, and Sun. Speaker’s Bureau: Alcon, Allergan, Bausch + Lomb, Eyevance, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, and Sun.
Selina R. McGee, OD, FAAO, Dipl ABO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Cynosure, Dompe, Eyevance, Horizon, Kala Pharmaceuticals, Lumenis, Novartis, Optovue, Versant, and Vertical. Speaker’s Bureau: Allergan, Lumenis, and Optovue.
Leslie O’Dell, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Bausch + Lomb, Dompe, Eyevance, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, Oyster Point, Pharma, Sun Pharmaceutical Industries, Sight Sciences, and Tarsus. Speaker's Bureau: Allergan, Johnson & Johnson Vision, and Sight Sciences.
The Evolve staff and planners have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Kala Pharmaceuticals.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
1.00 program creditDouglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
